
As production ramps up, experts hope the vaccine will reach areas that are underprivileged and often hardest-hit.
With climate concerns growing, steel companies face an inevitable crunch. ArcelorMittal sees solutions, but the costs are likely to run into tens of billions of dollars in Europe alone.